Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: The FAST4WARD study

Authors

R. Fleischmann
J. Vencovsky
R. F. Van Vollenhoven
D. Borenstein
J. Box

Document Type

Journal Article

Publication Date

2009

Journal

Annals of the Rheumatic Diseases

Volume

68

Issue

6

Inclusive Pages

805-811

APA Citation

Fleischmann, R., Vencovsky, J., Van Vollenhoven, R., Borenstein, D., & Box, J. (2009). Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: The FAST4WARD study. Annals of the Rheumatic Diseases, 68 (6). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/2731